Not currently recruiting at University of California Health
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- I-Mab Biopharma Co. Ltd.
- ID
- NCT04341116
- Phase
- Phase 2/3 research study
- Study Type
- Interventional
- Participants
- Expecting 384 study participants
- Last Updated